Cristin-resultat-ID: 1230903
Sist endret: 22. april 2016, 11:53
NVI-rapporteringsår: 2014
Resultat
Vitenskapelig artikkel
2014

Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis.

Bidragsytere:
  • Knut Anders Mosevoll
  • Roald Lindås
  • Øystein Wendelbo
  • Øystein Bruserud og
  • Håkon Reikvam

Tidsskrift

SpringerPlus
ISSN 2193-1801
e-ISSN 2193-1801
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2014
Publisert online: 2014
Trykket: 2014
Volum: 3
Hefte: 1
Sider: 1 - 9
Artikkelnummer: 571
Open Access

Importkilder

Scopus-ID: 2-s2.0-84909999927
Scopus-ID: 2-s2.0-84933039526

Klassifisering

Vitenskapsdisipliner

Hematologi

Beskrivelse Beskrivelse

Tittel

Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis.

Sammendrag

The initial evaluation of patients with suspected deep vein thrombosis includes the use of biomarkers reflecting activation of the coagulation system. However, the thromboembolic process and neighboring inflammatory responses also affect endothelial cells, and endothelial cell markers may therefore be altered by the disease. In the present population-based single-center study, we investigated the plasma levels of the endothelium-specific biomarkers soluble E-selectin and endocan in a consecutive and unselected group of 120 patients admitted to hospital for suspected deep vein thrombosis. Blood samples were collected when patients arrived at the hospital. DVT patients showed evidence for an acute phase reaction with increased serum C-reactive protein levels, but this was similar to many other patients admitted with suspected but not verified thrombosis. Plasma endocan and E-selectin levels did not differ between patients with thrombosis, healthy controls and the patients without verified thrombosis (i.e. patients with other causes of their symptoms, including various inflammatory and non-inflammatory conditions). However, the combined use of endothelial biomarkers, C-reactive protein and D-dimer could be used to identify patient subsets with different frequencies of venous thrombosis. Thus, analysis of plasma biomarker profiles including endothelial cell markers may be helpful in the initial evaluation of patients with deep vein thrombosis.

Bidragsytere

Knut Anders Mosevoll

  • Tilknyttet:
    Forfatter
    ved Klinisk institutt 2 ved Universitetet i Bergen

Roald Lindås

  • Tilknyttet:
    Forfatter
    ved Medisinsk avdeling ved Helse Bergen HF - Haukeland universitetssykehus

Øystein Wendelbo

  • Tilknyttet:
    Forfatter
    ved Medisinsk avdeling ved Helse Bergen HF - Haukeland universitetssykehus

Øystein Bruserud

  • Tilknyttet:
    Forfatter
    ved Klinisk institutt 2 ved Universitetet i Bergen
  • Tilknyttet:
    Forfatter
    ved Medisinsk avdeling ved Helse Bergen HF - Haukeland universitetssykehus

Håkon Reikvam

  • Tilknyttet:
    Forfatter
    ved Medisinsk avdeling ved Helse Bergen HF - Haukeland universitetssykehus
1 - 5 av 5